FIGURE 2.
Analysis of purified nanobodies. (A) His-tagged nb14 and nb53 with a predicted size of 15 kDa were detected by SDS-PAGE and Western blotting. (B) Detection of the binding activities of nb14 or nb53 to sp239 by iELISA. The PCV2-cap protein was used as a negative control. Data were processed with triplicate experiments and are presented as the means ± SDs. (C) The nb14 and nb53 interact with sp239, rHEV-239, Sar-55-239, and Kernow C1-239 protein by iELISA. The 1B5 and nb anti-PCV2 antibodies were used as positive and negative controls, respectively.
